University of California

Neuvivo, Inc.

Leah Price

Arasteh Ari Azhir

Michael S Mcgrath

Bruce D Forrest

Provided herein are methods and compositions for the treatment of ALS using chlorite or a pharmaceutical composition comprising sodium chlorite, for a target ALS patient population. Also provided herein are methods for identifying a target ALS patient population likely to be responsive to treatment with chlorite or a pharmaceutical composition comprising sodium chlorite, the methods including identifying ALS patients with elevated plasma C-reactive protein (CRP) levels and/or patients age 40-65, sporadic ALS pathology, or combinations thereof.

Growing community of inventors

Karmiel, Israel

Leah Price